...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith AGM Corporation Update Slides and Webcast

narmac, sorry to say, but Don M reminds me of the idiom...."jack of the trades, master of none".

What Zenith needs to do is to focus on one thing at a time for it to succeed in bringing in seed money to continue its quest to keep exploring other prospects seeing that he has no interest as it seems to put out an IPO.

Zenith seems to enjoy the ride but seems to put aside the potential consequences that one day the well will dry up for good to the detriment of its shareholders...But I do see great potential here.  

Just an observation....Koo

 

Share
New Message
Please login to post a reply